RX Note

DECEMBER 25, 2024

Introduction Consumers from private hospitals and clinics are provided with a huge range of brand choices , being it original or generic brand. Off label use information can be found here too. 2005 SPS - Prescribing by generic or brand name in primary care SPS - Example medicines to prescribe by brand name in primary care

Biosimilars 52

Biosimilars Community Pharmacies Labelling Communication 52

RX Note

JULY 29, 2023

Cephalexin (oral) for UTI prophylaxis Paediatric Protocols for Malaysian Hospitals, 2019: 5 mg/kg ON Frank Shann Drug Doses, 2017 : 12.5 Spironolactone (oral) Paediatric Protocols for Malaysian Hospitals, 2019: 1 mg/kg/dose BD as anti-heart failure medication. mg/kg (adult 5 mg) daily oral. More examples are listed below.

Labelling 40

Labelling Hospitals Dosage 40

Pharmacy Joe

SEPTEMBER 7, 2022

Milrinone labeling suggests a renal dose adjustment for patients with creatinine clearance between 10 and 50 mL/min but has no recommendations or data available for patients with ESRD or who are receiving CRRT. To get immediate access, go to pharmacyjoe.com/quarterly.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

SEPTEMBER 7, 2022

Milrinone labeling suggests a renal dose adjustment for patients with creatinine clearance between 10 and 50 mL/min but has no recommendations or data available for patients with ESRD or who are receiving CRRT. To get immediate access, go to pharmacyjoe.com/quarterly.

Hospitals 40

Hospitals Inpatient Labelling 40

PharmaShots

MARCH 9, 2023

She developed various mobile technologies and pioneered early electronic labels including NFC tags, which helped Thin Film Electronics win the Wall Street Innovation Award and the Global Technology Award. LinkedIn Total experience: 16 yrs. Present company and time period: Johnson & Johnson (13 yrs. Vita Award for Clinical Research.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

PharmaShots

APRIL 13, 2023

Abbott spun off its hospital product business into an independent company called Hospira on the other hand its breakthrough drug Humira achieved a global sale of more than $0.8B Bayer’s Matetial Science subgroup moved ahead effectively in 2004 showing a rise of 15.3% in the year 2006, thereby depicting a growth rate of 5.6%.

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

European Pharmaceutical Review

SEPTEMBER 22, 2023

From there her research shifted to the immunology field, specialising in haematopoietic stem cell transplantation and vaccinology at Geneva University Hospitals. She has extensive experience in the biopharmaceutical industry and previously served as Chief Scientific Officer for Novimmune from 2005. Landry I, Kanekiyo M, Aluri J, et al.

Immunity 97

Immunity Immunization Vaccines Communication 97